These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 30442100)
1. Gadoxetic acid-enhanced magnetic resonance imaging significantly influences the clinical course in patients with colorectal liver metastases. Sibinga Mulder BG; Visser K; Feshtali S; Vahrmeijer AL; Swijnenburg RJ; Hartgrink HH; van den Boom R; Burgmans MC; Mieog JSD BMC Med Imaging; 2018 Nov; 18(1):44. PubMed ID: 30442100 [TBL] [Abstract][Full Text] [Related]
2. Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study. Görgec B; Hansen I; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bisschops RHC; Bollen TL; Bosscha K; Burgmans MC; Cappendijk V; De Boer MT; D'Hondt M; Edwin B; Gielkens H; Grünhagen DJ; Gillardin P; Gobardhan PD; Hartgrink HH; Horsthuis K; Kok NFM; Kint PAM; Kruimer JWH; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Morone M; Pennings JP; Peringa J; Te Riele WW; Vermaas M; Wicherts D; Willemssen FEJA; Zonderhuis BM; Bossuyt PMM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J; BMC Cancer; 2021 Oct; 21(1):1116. PubMed ID: 34663243 [TBL] [Abstract][Full Text] [Related]
3. Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan. Jhaveri KS; Fischer SE; Hosseini-Nik H; Sreeharsha B; Menezes RJ; Gallinger S; Moulton CE HPB (Oxford); 2017 Nov; 19(11):992-1000. PubMed ID: 28760631 [TBL] [Abstract][Full Text] [Related]
4. Feasibility of Routine Application of Gadoxetic Acid-Enhanced MRI in Combination with Diffusion-Weighted MRI for the Preoperative Evaluation of Colorectal Liver Metastases. Tanaka M; Kishi Y; Esaki M; Nara S; Miyake M; Hiraoka N; Nagino M; Shimada K Ann Surg Oncol; 2016 Nov; 23(12):3991-3998. PubMed ID: 27357179 [TBL] [Abstract][Full Text] [Related]
5. Comparison of gadoxetic acid-enhanced dynamic MR imaging and contrast-enhanced computed tomography for preoperative evaluation of colorectal liver metastases. Asato N; Tsurusaki M; Sofue K; Hieda Y; Katsube T; Kitajima K; Murakami T Jpn J Radiol; 2017 Apr; 35(4):197-205. PubMed ID: 28251499 [TBL] [Abstract][Full Text] [Related]
6. Role of gadoxetic acid-enhanced magnetic resonance imaging in the preoperative evaluation of small hepatic lesions in patients with colorectal cancer. Cho JY; Lee YJ; Han HS; Yoon YS; Kim J; Choi Y; Shin HK; Lee W World J Surg; 2015 May; 39(5):1161-6. PubMed ID: 25609116 [TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy. Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of CT, MRI and PET/CT in patients with suspected colorectal liver metastases: the superiority of MRI. Schulz A; Viktil E; Godt JC; Johansen CK; Dormagen JB; Holtedahl JE; Labori KJ; Bach-Gansmo T; Kløw NE Acta Radiol; 2016 Sep; 57(9):1040-8. PubMed ID: 26622057 [TBL] [Abstract][Full Text] [Related]
9. Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases. Zech CJ; Korpraphong P; Huppertz A; Denecke T; Kim MJ; Tanomkiat W; Jonas E; Ba-Ssalamah A; Br J Surg; 2014 May; 101(6):613-21. PubMed ID: 24652690 [TBL] [Abstract][Full Text] [Related]
10. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases. Ghorra C; Pommier R; Piveteau A; Rubbia-Brandt L; Vilgrain V; Terraz S; Ronot M Eur Radiol; 2021 Apr; 31(4):2451-2460. PubMed ID: 33025173 [TBL] [Abstract][Full Text] [Related]
11. Gadoxetic acid-enhanced MRI and diffusion-weighted imaging for the detection of colorectal liver metastases after neoadjuvant chemotherapy. Yu MH; Lee JM; Hur BY; Kim TY; Jeong SY; Yi NJ; Suh KS; Han JK; Choi BI Eur Radiol; 2015 Aug; 25(8):2428-36. PubMed ID: 25899413 [TBL] [Abstract][Full Text] [Related]
12. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques. Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre. Chan VO; Das JP; Gerstenmaier JF; Geoghegan J; Gibney RG; Collins CD; Skehan SJ; Malone DE Ir J Med Sci; 2012 Dec; 181(4):499-509. PubMed ID: 22426901 [TBL] [Abstract][Full Text] [Related]
14. Impact of baseline gadoxetic acid-enhanced liver magnetic resonance and diffusion-weighted imaging in resectable colorectal liver metastases: A prospective, monocentric study. Moretto R; Borelli B; Boraschi P; Roffi N; Donati F; Antoniotti C; Della Pina C; Colombatto P; Balestri R; Signori S; Gigoni R; Guidoccio F; Volterrani D; Masi G; Cremolini C; Urbani L Surg Oncol; 2022 Sep; 44():101836. PubMed ID: 35998501 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis. Choi SH; Kim SY; Park SH; Kim KW; Lee JY; Lee SS; Lee MG J Magn Reson Imaging; 2018 May; 47(5):1237-1250. PubMed ID: 28901685 [TBL] [Abstract][Full Text] [Related]
16. Is MRI of the Liver Needed During Routine Preoperative Workup for Colorectal Cancer? Kang SI; Kim DW; Cho JY; Park J; Lee KH; Son IT; Oh HK; Kang SB Dis Colon Rectum; 2017 Sep; 60(9):936-944. PubMed ID: 28796732 [TBL] [Abstract][Full Text] [Related]
17. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation. Scharitzer M; Ba-Ssalamah A; Ringl H; Kölblinger C; Grünberger T; Weber M; Schima W Eur Radiol; 2013 Aug; 23(8):2187-96. PubMed ID: 23519439 [TBL] [Abstract][Full Text] [Related]
18. MRI in addition to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): an international, multicentre, prospective, diagnostic accuracy trial. Görgec B; Hansen IS; Kemmerich G; Syversveen T; Abu Hilal M; Belt EJT; Bosscha K; Burgmans MC; Cappendijk VC; D'Hondt M; Edwin B; van Erkel AR; Gielkens HAJ; Grünhagen DJ; Gobardhan PD; Hartgrink HH; Horsthuis K; Klompenhouwer EG; Kok NFM; Kint PAM; Kuhlmann K; Leclercq WKG; Lips DJ; Lutin B; Maas M; Marsman HA; Meijerink M; Meyer Y; Morone M; Peringa J; Sijberden JP; van Delden OM; van den Bergh JE; Vanhooymissen IJS; Vermaas M; Willemssen FEJA; Dijkgraaf MGW; Bossuyt PM; Swijnenburg RJ; Fretland ÅA; Verhoef C; Besselink MG; Stoker J; Lancet Oncol; 2024 Jan; 25(1):137-146. PubMed ID: 38081200 [TBL] [Abstract][Full Text] [Related]
19. Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with ¹⁸F-FDG PET/CT. Oh JW; Oh SN; Choi JI; Choi MH; Yoo IeR; Lee MA; Yoo YK; Oh ST Biomed Res Int; 2016; 2016():8412071. PubMed ID: 27022613 [TBL] [Abstract][Full Text] [Related]
20. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging. Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]